(19)
(11) EP 4 716 555 A1

(12)

(43) Date of publication:
01.04.2026 Bulletin 2026/14

(21) Application number: 24838813.4

(22) Date of filing: 09.07.2024
(51) International Patent Classification (IPC): 
A61K 47/68(2017.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; A61K 47/6855; A61K 47/6849; A61K 47/6845; A61K 47/6851; A61K 47/6877; A61K 47/68031; A61K 47/68037; A61K 47/6889; C07K 16/32; C07K 2317/24
(86) International application number:
PCT/CN2024/104515
(87) International publication number:
WO 2025/011561 (16.01.2025 Gazette 2025/03)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 10.07.2023 WO PCT/CN2023/106636

(71) Applicant: WUXI XDC SINGAPORE PRIVATE LIMITED
100 AM Singapore, 079027 (SG)

(72) Inventors:
  • ZHANG, Lin
    Shanghai 200131 (CN)
  • FAN, Qirui
    Shanghai 200131 (CN)
  • ZHAO, Yanjie
    Shanghai 200131 (CN)

(74) Representative: Modiano, Gabriella Diana et al
Modiano & Partners SA Steinsdorfstraße 14
80538 München
80538 München (DE)

   


(54) ANTIBODY-DRUG CONJUGATES AND PRODUCTION THEREOF